| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |